The IASLC 2019 Latin America Conference on Lung Cancer - October 17-19

Introducing JTO Clinical and Research Reports (JTOCRR)

Learn more about the JTOCRR

Sixth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic

Submit Your Abstract

The IASLC 2019 North America Conference on Lung Cancer - October 10-12

Virtual Library

Together, we can break through limits

Learn More

IASLC 2019 World Conference on Lung Cancer (WCLC)

CME Information Virtual Library

At IASLC, Our Mission is

To Conquer Thoracic Cancers Worldwide

On Nearly Every Continent, Our Members Are Working Toward a World Without Lung and Thoracic Cancers

MembersXnumbers-info_graphic_0319636935317642360195

Journal of Thoracic Oncology

Lung and thoracic specialists count on the IASLC’s Journal of Thoracic Oncology to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal focusing on lung and thoracic cancers, the journal is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community.

Go to the Journal

IASLC News

October 14, 2019

IASLC Open Comment Period On “Multidisciplinary Recommendations For ...

The International Association for the Study of Lung Cancer today announces an open comment period for the “IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant Therapy” paper.

October 11, 2019

Arizona Lung Cancer Researcher: Lung Cancer Screening Guidelines Do Not ...

National lung cancer screening guidelines are inadequate todiagnose patients who contract lung cancer from occupational exposure,including first responders, according to a study reported today at theInternational Association for the Study of Lung Cancer’s North AmericaConference on Lung Cancer in Chicago.

September 10, 2019

IMpower131: Final Overall Survival Results of Carboplatin + ...

Patients with Stage IV squamous non-small cell lung cancer enrolled in clinical trial to test the immunotherapy atezolizumab and chemotherapy against chemotherapy alone experienced a longer survival rate, among a subgroup of patients with high PD-LI.

View News Archive

Events

View Event Calendar

Join Now - Become a Member

Join the only network of specialists working together to conquer lung and thoracic cancers worldwide. As a member, you can collaborate with a global team of thoracic oncology experts and gain access to the latest, ground-breaking research in lung cancer prevention, detection and treatment.

Join Now

Virtual Library

Visit the Virtual Library

Lung Cancer Staging Project

Be a Part of It

IASLC Publications

From specialized atlases to our award-winning textbook, IASLC publications are an invaluable educational resource for the thoracic oncology community.

View Publications